BUDGET IMPACT ANALYSIS OF TRIVERAM FOR THE TREATMENT OF HYPERTENSION IN ITALY

被引：0
|
作者：
Lanati, E. P. [1 ]
Orlando, V. L. [1 ]
Doratori, S. [2 ]
机构：
[1] MA Provider Srl, Milan, Italy
[2] Servier Italia, Rome, Italy
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV41
引用
收藏
页码：A643 / A643
页数：1
相关论文
共 50 条
  • [31] BUDGET IMPACT ANALYSIS OF SCHIZOPHRENIA TREATMENT IN INDONESIA
    Puspandari, D. A.
    Hafidz, F.
    Tsalatsita, R. M.
    VALUE IN HEALTH, 2019, 22 : S683 - S683
  • [32] Budget impact analysis of the adoption of new hypertension guidelines in Colombia
    Cesar Augusto Guevara-Cuellar
    Victoria Eugenia Soto
    María Isabel Molina-Echeverry
    Cost Effectiveness and Resource Allocation, 16
  • [33] BUDGET IMPACT ANALYSIS OF MELANOMA TREATMENT IN MEXICO
    Peniche-Otero, G.
    Herrera-Rojas, J.
    Ramirez-Ramirez, M. A.
    Nuno-Langre, C.
    Baeza-Cruz, G.
    Bolanos-Cornejo, D.
    VALUE IN HEALTH, 2012, 15 (04) : A212 - A212
  • [34] Prophylaxis against febrile neutropenia with pegfilgrastim in Italy: a budget impact analysis
    Rosti, Giovanni
    Lebboroni, Maria
    Cerchiari, Ario
    Katz, Pablo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2011, 12 (03) : 119 - 127
  • [35] Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy
    Bellone, Marco
    Di Virgilio, Roberto
    Di Rienzo, Paolo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (03) : 127 - 136
  • [36] Budget Impact Analysis of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly in Italy
    Baldo, Vincenzo
    Bellone, Marco
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2022, 23 (01) : 69 - 83
  • [37] BUDGET IMPACT ANALYSIS OF VASCULAR CLOSURE DEVICES (VCDs) IN ITALY AND SPAIN
    Nazareth, T.
    Busutil, R.
    Perrone, F.
    Espallardo, O.
    Mauro, E.
    Saadi, R.
    VALUE IN HEALTH, 2012, 15 (07) : A347 - A347
  • [38] BUDGET IMPACT OF RVIII-SINGLECHAIN IN MODERATE AND SEVERE HAEMOPHILIA A TREATMENT IN ITALY
    Yan, S.
    Tomic, R.
    Panebianco, M.
    Dlotko, E.
    Stern, L.
    Marino, R.
    HAEMOPHILIA, 2022, 28 : 42 - 43
  • [39] Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy
    Ruggeri, M.
    Basile, M.
    Coretti, S.
    Drago, C.
    Cicchetti, A.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (04) : 479 - 490
  • [40] Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients
    Restelli, Umberto
    Alberti, Alfredo
    Lazzarin, Adriano
    Bonfanti, Marzia
    Nappi, Carmela
    Croce, Davide
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (01) : 7 - 12
12345